ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
March 27 2025 - 8:27AM
ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a
next generation biotech, genomics and consumer products company,
today announced that they will be presenting full year 2024
financial results, and a review of current Company strategy, on a
virtual conference call hosted by Renmark Financial on March 31,
2025 at 11:00 AM EST. A press release detailing these results will
be issued prior to the virtual conference call. ProPhase Labs Inc.
welcomes stakeholders, investors, and other individual followers to
register and attend this live event.
Investors interested in participating in this
live event will need to register using the link below. After the
event, a replay will be available on the company’s investor
website.
REGISTER HERE:
https://www.renmarkfinancial.com/events/fourth-quarter-year-end-2024-results-virtual-conference-call-nasdaq-prph-PA3S8FxovQ
- To ensure smooth
connectivity, please access this link using the latest version of
Google Chrome.
About ProPhase LabsProPhase
Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech,
genomics and consumer products company. Our goal is to create a
healthier world with bold action and the power of insight. We’re
revolutionizing healthcare with industry-leading Whole Genome
Sequencing solutions, while developing potential game changer
diagnostics and therapeutics in the fight against cancer. This
includes a potentially life-saving cancer test focused on early
detection of esophageal cancer and potential breakthrough cancer
therapeutics with novel mechanisms of action. We develop,
manufacture, and commercialize health and wellness solutions to
enable people to live their best lives. We are committed to
executional excellence, smart diversification, and a synergistic,
omni-channel approach. ProPhase Labs’ valuable subsidiaries, their
synergies, and significant growth underscore our potential for
long-term value.
Media Relations and Institutional
Investor Contact:ProPhase Labs,
Inc.investorrelations@prophaselabs.com
Retail Investor Relations
Contact:Renmark Financial CommunicationsJohn
Boidman212-812-7680Jboidman@renmarkfinancial.com
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Jun 2025 to Jul 2025
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Jul 2024 to Jul 2025